Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Net Shares Issued and Repurchased (2019 - 2021)

Valneva SE (VALN) posted Net Shares Issued and Repurchased of $1.1 million for Q1 2026, down 84.93% sequentially from $7.1 million in Q3 2025.

Analysis

Valneva SE (VALN) Net Shares Issued and Repurchased (2019 - 2021) Analysis & Trends

Valneva SE has reported Net Shares Issued and Repurchased for 6 years, with the latest figure at $1.1 million in Q1 2026.

  • Quarterly Net Shares Issued and Repurchased changed N/A year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.0 million (down 50.58% YoY) and the FY2024 annual result came in at $61.8 million, up 23921.58% from the prior year.
  • Net Shares Issued and Repurchased retreated to $1.1 million in Q1 2026 per VALN's latest filing, from $7.1 million in the prior quarter.
  • Over five years, Net Shares Issued and Repurchased peaked at $310.0 million in Q3 2023 and troughed at -$310.1 million in Q2 2023.
  • A 5-year average of $31.9 million and a median of $7.1 million in 2025 frame the typical range for Net Shares Issued and Repurchased.
  • The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased slumped 79.64% in 2024, then sank 88.68% in 2025.
  • Over 5 years, Net Shares Issued and Repurchased stood at $193.7 million in 2022, then surged by 60.05% to $310.0 million in 2023, then slumped by 100.11% to -$343019.1 in 2024, then jumped by 2183.05% to $7.1 million in 2025, then sank by 84.93% to $1.1 million in 2026.
  • According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $1.1 million, $7.1 million, and $22.8 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 239,089.93
Sep 30, 2021 246,471.05
Dec 31, 2020 256,342.32
Dec 31, 2019 23,244.64